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Microenvironment regulates the 
expression of miR-21 and tumor 
suppressor genes PTEN, PIAS3 and 
PDCD4 through ZAP-70 in chronic 
lymphocytic leukemia
Júlia Carabia, Cecilia Carpio, Pau Abrisqueta, Isabel Jiménez, Noelia Purroy, Eva Calpe, Carles 
Palacio, Francesc Bosch & Marta Crespo
Chronic lymphocytic leukemia (CLL) cells are highly dependent on microenvironment, being the BCR 
pathway one key player in this crosstalk. Among proteins participating, ZAP-70 enhances response 
to microenvironmental stimuli. MicroRNA-21 (miR-21) is overexpressed in diverse neoplasias 
including CLL, where it has been associated to refractoriness to fludarabine and to shorter time to 
progression and survival. To further elucidate the role of ZAP-70 in the biology of CLL, we studied its 
involvement in miR-21 regulation. MiR-21 expression was higher in CLL cells with high ZAP-70. Ectopic 
expression of ZAP-70 induced transcription of miR-21 via MAPK and STAT3, which subsequently 
induced downregulation of tumor suppressors targeted by miR-21. The co-culture of primary CLL cells 
mimicking the microenvironment induced ZAP-70 and miR-21 expression, as well as downregulation 
of miR-21 targets. Interestingly, the increase in miR-21 after co-culture was significantly impaired by 
ibrutinib, indicating that the BCR signaling pathway is involved in its regulation. Finally, survival of CLL 
cells induced by the co-culture correlated with miR-21 upregulation. In conclusion, stimuli from the 
microenvironment regulate miR-21 and its targeted tumor suppressor genes via a signaling pathway 
involving ZAP-70, thus contributing to the cytoprotection offered by the microenvironment particularly 
observed in CLL cells expressing ZAP-70.
Microenvironment found in bone marrow and lymph nodes supports survival, proliferation and drug resist-
ance in chronic lymphocytic leukemia (CLL)1. Indeed, CLL cells are highly dependent on interactions with the 
microenvironment, as evidenced by the spontaneous apoptosis occurring ex vivo and the clinical relevance of 
impeding the access of CLL cells to lymph nodes and bone marrow that targeted treatments such as BTK or PI3K 
inhibitors induce2. The B-cell receptor (BCR) is one of the key players involved in the crosstalk between CLL 
cells and the microenvironment with a critical role in pathogenesis and prognosis in CLL. Accordingly, different 
factors related to increased signaling in the BCR pathway, such as unmutated IGHV genes3, high expression of 
ZAP-70 protein4, or increased serum levels of CCL35 are associated with an adverse prognosis in CLL. Expression 
of ZAP-70 in CLL cells has been related to enhanced response to BCR stimulation, as well as to increased response 
to diverse migrative and survival stimuli from the microenvironment6. Moreover, we recently described how 
mimicking the microenvironment ex vivo leads to the upregulation of ZAP-70 protein in primary CLL cells and 
how the small percentage of Ki-67 positive cells in peripheral blood (PB) of patients with ZAP-70 are highly 
enriched in CLL cells expressing ZAP-707.
Aberrant expression of diverse microRNAs (miRNAs) has been related to pathogenesis and clinical outcome 
in patients diagnosed with CLL (reviewed in ref.8). Among them, miR-21 is overexpressed in a wide variety of 
tumors, where it participates in different oncogenic processes9 and has been associated with poor prognosis10. 
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Interestingly, overexpression of miR-21 in mice leads to a pre-B malignant lymphoid-like phenotype, demon-
strating that miR-21 is a genuine oncogene11. Also, miR-21 has been shown to be overexpressed in activated B 
cells, particularly in germinal center and memory B cells. Its expression can be induced by IL-4, IL-4 and CD40L, 
or by BCR stimulation, suggesting that it may help to maintain B-cell hyperactivation which would prime B cells 
for malignant transformation12.
In CLL, miR-21 is overexpressed13,14 and it has been associated to refractoriness to fludarabine15, shorter over-
all survival and higher probability of progression16. Against this background, and in order to further elucidate 
the role of ZAP-70 in the crosstalk between CLL cells and the microenvironment, we studied the potential rela-
tionship between ZAP-70 protein and miR-21 and how it would be influenced by the microenvironment. Herein 
we define the correlation and participation of ZAP-70 protein in the regulation of miR-21 expression. Briefly, 
we have showed that stimuli from the microenvironment are capable of regulating the expression of miR-21 
and its targeted tumor suppressor genes (PTEN, PDCD4 and PIAS3) via a signaling pathway involving ZAP-70, 
MAPK and STAT3 transcription factor, which correlates with the induction of survival by the microenviron-
ment. These results help to enlighten the biology behind the adverse clinical outcome of patients with CLL and 
high expression of ZAP-70 and describe the participation of miR-21 in the crosstalk between CLL cells and the 
microenvironment.
Results
Expression of microRNA miR-21 is significantly higher in CLL cells with high expression of ZAP-
70. The relationship of miR-21 expression with indicators of bad prognosis in CLL and its role in B lympho-
cytes activation and oncogenesis prompted us to initially analyze the differential expression of miR-21 according 
to ZAP-70 status in primary cells from patients diagnosed with CLL. For that we purified CD19+ cells by means 
of magnetic separation from peripheral blood mononuclear cells (PBMC) in 33 patients diagnosed with CLL 
with either high (N = 17) or low (N = 16) expression of ZAP-70 as assessed by flow cytometry. Purity, further 
determined by flow cytometry, was superior to 90% in all cases. We then determined the expression of miR-21 by 
QRT-PCR and found that it was significantly higher in patients with high expression of ZAP-70 (mean miR-21 
expression: 5.781 ± 1.517) than in patients with low ZAP-70 expression (mean miR-21 expression: 1.149 ± 0.5355; 
p = 0.0183) (Fig. 1). The main characteristics of the patients are detailed in Table 1.
In B cells, ZAP-70 protein enhances the induction of expression of miR-21 after BCR stimu-
lation via MAPK and STAT3 activation. ZAP-70 protein participates in different signaling pathways 
that modulate the interaction of CLL cells with the microenvironment. To elucidate if ZAP-70 protein could 
be directly involved in miR-21 upregulation in CLL, we stimulated the BCR of Ramos malignant B-cells stably 
Figure 1. Expression of miR-21 is significantly higher in patients with CLL with high expression of ZAP-70. 
Expression levels of miR-21 were measured by QRT-PCR in PBMC from 33 patients diagnosed with CLL with 
high ZAP-70 (N = 17) or low ZAP-70 (N = 16), as indicated at the bottom of the histogram. *P < 0.05.
Gender (F/M in %) 65/35
Age (years) 65 (56–76)
17p deletion (N/P in %) 86 /14
13q deletion (N/P in %) 41/59
11q deletion (N/P in %) 84/16
Complex karyotype (No/Yes in %) 90/10
ZAP-70 categorized (Low/High in %) 56/44
IGHV (UM/M in %) 54/46
CLL cells (% CD19/CD5+) 87 (80–94)
Table 1. Characteristics of the patients. Data are expressed as median (Q1–Q3) or in percentages. M: Mutated; 
UM: Unmutated; N: Negative; P: Positive.
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transfected with a vector expressing a GFP-ZAP-70 fusion protein or GFP-only as a control. After 4 hours of 
anti-IgM stimulation we observed a 2.217 fold increase of the primary transcript of miR-21 in control Ramos 
cells (from 0.911 AU ± 0.055 to 2.019 AU ± 0.487), whereas in Ramos-ZAP-70 this fold increase went up to 7.387 
(from 0.63 AU ± 0.057 to 4.654 AU ± 0.484) (Fig. 2a). After 12 hours, however, the increase was smaller and only 
Figure 2. ZAP-70 protein overexpression enhances the induction of miR-21 expression after BCR stimulation 
in B cells via MAPK and STAT3 activation. (a–b) Ramos stable transfectants were stimulated with 5 µg/mL 
F(ab’)2 anti-IgM for 4 and 12 hours. Expression levels of primary miR-21 (a) and miR-21 (b) were measured by 
QRT-PCR. (c–d) Ramos GFP-ZAP-70 cells were stimulated with 5 µg/mL F(ab’)2 anti-IgM for 5 minutes after 
pre-incubation for 1 hour with 5 µM or 10 µM LY294002 for Akt inhibition or 50 µM or 100 µM PD98059 for 
ERK1/2 inhibition. Immunobloting analysis confirmed the inhibition of phosphorylation of Akt and ERK1/2 
(Jurkat cells treated with PV were used as positive control) (c) and expression levels of miR-21 were measured 
by QRT-PCR after 12 hours (d). (e–f) Ramos stable transfectants were stimulated with 5 µg/mL F(ab’)2 anti-
IgM for 5 minutes and pre-treated 1 hour with 5 µM JSI-124 for STAT3 inhibition. Immunobloting analysis 
confirmed the inhibition of STAT3 phosphorylation (Jurkat cells treated with PV were used as positive control) 
(e) and expression levels of miR-21 were measured by QRT-PCR after 48 hours (f). *P < 0.05, **P < 0.005.
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observed in ZAP-70 expressing cells. On the contrary, mature miR-21 expression was only slightly increased 
after 4 hours of BCR stimulation (1.619 fold increase in control Ramos cells, and 2.485 fold increase in Ramos 
GFP-ZAP-70 cells), whereas after 12 hours the increase in expression was much higher, especially in cells express-
ing ZAP-70 (10.462 fold increase) (Fig. 2b). These results are in agreement with a regulation of miR-21 at the 
transcriptional level, since we observe a fast increment in its primary transcript followed by an increase in mature 
miR-21 levels after processing. Therefore, the results indicate that ZAP-70 activation after BCR signaling pathway 
stimulation is involved in the induction of the transcription of the primary transcript of miR-21 and subsequent 
increase in mature miR-21 levels.
In order to dissect the signaling pathway involved in the upregulation of miR-21 after ZAP-70 activation 
via BCR crosslinking we inhibited for 1 hour both Akt and ERK1/2 kinases using LY294002 (5 µM or 10 µM) or 
PD98059 (50 µM or 100 µM), respectively, in Ramos GFP-ZAP-70 B cells. In this system, the inhibition of ERK1/2 
kinase completely abrogated the rise in miR-21 observed after BCR stimulation, whereas Akt inhibition had no 
effect (Fig. 2c and d).
The stimulation of the BCR signaling pathway leads to the nuclear translocation and activation of differ-
ent transcription factors, including STAT3, which binds to the promoter of the primary transcript of miR-2117. 
Therefore, we assessed the role of STAT3 in BCR-induced miR-21 upsurge by pharmacological inhibition. For 
that we incubated Ramos transfectants with 5 µM JSI-124 for 1 hour and then stimulated the BCR and analyzed 
miR-21 expression. After 48 hours, we observed that the inhibition of STAT3 blocked the upregulation of miR-
21 after BCR stimulation regardless the expression of ZAP-70 (Fig. 2e and f). Altogether these results indicate 
that the activation of the BCR signaling pathway, which is enhanced when ZAP-70 is expressed, is able to induce 
an increase in mature miR-21 via transcriptional activation of the primary transcript after a signaling pathway 
involving MAPK and STAT3 activation.
The tumor suppressor genes PTEN, PDCD4 and PIAS3, targeted by miR-21, are downregulated 
after BCR stimulation. MicroRNA miR-21 has been shown to target different genes, mostly involved in 
regulation of proliferation and survival9, including tumor suppressors such as PTEN18, PDCD419 and PIAS320. 
In order to assess if these genes were also modulated by miR-21 in malignant B cells, we stimulated the BCR 
of Ramos GFP and Ramos GFP-ZAP-70 cells and observed a modest downregulation at the protein level of 
PTEN, PDCD4 and PIAS3 (Fig. 3a and b). In addition, the global analysis of gene expression changes in Ramos 
GFP-ZAP-70 transfectants by Gene Set Enrichment Analysis (GSEA) showed a significant downregulation of 
miR-21 targets gene set after BCR stimulation (enrichment score: −0.28; nominal p-value: 0.049; Fig. 3c). The 
targets of miR-21 defined in the gene set where also downregulated when comparing Ramos GFP-ZAP-70 cells 
and Ramos GFP, both stimulated with anti-IgM, although the difference did not reach statistical significance 
(enrichment score: −0.23; nominal p-value: 0.44) (Fig. 3d).
Co-culture of primary CLL cells with BMSC, CD40L and CpG ODN induces the expression of 
miR-21. With the aim of in vitro reproducing the microenvironment that CLL cells find in the proliferative 
centers in vivo, we have developed a co-culture system of primary CLL cells with the bone marrow stromal cell 
(BMSC) cell line UE6E7T-2, soluble CD40L, CpG ODN and anti-IgM which has been reported elsewhere21. 
Using this approach we observed an increase in survival, proliferation and chemoresistance in primary CLL 
cells. Interestingly, the co-culture also induced activation and modulation of expression of different molecules, 
including increased expression of ZAP-707 and phosphorylation of ERK1/2 and STAT322. Since we observed 
the involvement of the ZAP-70-ERK1/2-STAT3 axis in the induction of miR-21 expression in Ramos cells, we 
co-cultured primary CLL cells from 40 patients and observed a relative mean increase of 2.57 fold of miR-21 
expression after 48 hours compared to the expression observed in cells kept in suspension (from 7.921 AU ± 1.091 
to 20.35 AU ± 1.938; p < 0.0001) (Fig. 4a). This increase was accompanied by a concomitant downregulation of 
miR-21 targets PTEN, PDCD4 and PIAS3 at the mRNA level (PTEN from 13.76 AU ± 2.853 to 3.485 AU ± 0.878; 
PDCD4 from 52.3 AU ± 9.01 to 9.085 AU ± 1.371; PIAS3 from 13.07 AU ± 1.988 to 4.353 AU ± 0.569; p < 0.001 
in all) (Fig. 4b). The herein described co-culture system is able to mimic the microenvironment found by pri-
mary CLL cells in lymph nodes, a tissue that shows constitutively active BCR signaling, as previously reported 
by Herishanu et al.23. Therefore, we interrogated the PubMed GEO database of expression data from paired sam-
ples of lymph nodes (LN), bone marrow (BM) and PB from patients with CLL for the differential expression of 
miR-21 and its targets in the different compartment. By paired Student’s t- test we observed that miR-21 expres-
sion level was significantly increased in LNs from patients with CLL compared to PB (from 1.931 ± 0.019 to 
1.988 AU ± 0.028; p = 0.017) (Fig. 4c). Moreover, the expression of PTEN was lower in LN compared to PB (from 
2.379 AU ± 0.013 to 2.325 AU ± 0.2; p = 0.019) (Fig. 4d), whereas PIAS3 and PDCD4 did not show any significant 
change (data not shown). Finally, we aimed to assess the role of the BCR signaling pathway in the induction of 
miR-21 in co-cultured primary CLL cells. For that we treated primary CLL cells from 13 patients with 5 µM BTK 
inhibitor ibrutinib for 1 hour before co-culturing them for 48 hours which significantly impaired miR-21 upreg-
ulation, in further agreement with the involvement of the BCR signaling pathway in the regulation of miR-21 
expression in CLL (Fig. 4e).
The increase in survival induced by co-culture of primary CLL cells with BMSC, CD40L and 
CpG ODN correlates with the upregulation of miR-21. Finally, we aimed to study the implication 
of microRNA miR-21 in the induction of survival and proliferation by the microenvironment in primary CLL 
cells. For that, we co-cultured primary cells from 11 patients diagnosed with CLL for 48 hours in our co-culture 
system or in suspension and measured the increase in survival by means of annexinV-PI exclusion, and the 
proliferation by the percentage of Ki-67 positive CD19+/CD5+ CLL cells. As expected, the co-culture induced 
an increase in survival, proliferation, and the expression of miR-21 (Fig. 5). Interestingly, we also observed that 
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the cytoprotection conferred by the microenvironment was significantly correlated to the fold change increase 
in miR-21 expression observed (r2 = 0.479, p = 0.018; Fig. 5a) indicating that miR-21 plays a role, among other 
factors, in that cytoprotection. The induction of proliferation, however, did not correlate with miR-21 increase 
(Fig. 5b).
Discussion
The crosstalk between CLL cells and the microenvironment is able to strongly modulate biological processes in 
these cells, such as sustained survival, proliferation, circulation between different compartments, lack of response 
to apoptotic signals, and response to different therapeutic agents. CLL cells that express unmutated IGHV genes 
have an increased BCR signaling, partly because of the usual concomitant expression of ZAP-70 protein which 
directly enhances that signaling24,25. Moreover, CLL cells temporary residing in the LNs activate downstream 
elements of the BCR signaling pathway, regardless of the IGHV mutational status23. Therefore, we believe that 
Figure 3. The tumor suppressor genes PTEN, PDCD4 and PIAS3, targeted by miR-21, are downregulated after 
BCR stimulation. (a,b) Ramos stable transfectants were stimulated with 5 µg/mL F(ab’)2 anti-IgM for 5 minutes 
and 48 hours. Enhanced STAT3 and ERK1/2 phosphorylation was observed in IgM-BCR stimulated cells for 
5 minutes. PTEN, PIAS3 and PDCD4 downregulation was observed in IgM-BCR stimulated cells after 48 hours. 
(c,d) Gene set enrichment analysis (GSEA) for Gabriely_miR-21_targets gene set (N = 289). The panel shows 
GSEA of Ramos GFP-ZAP-70 stimulated with 5 µg/mL F(ab’)2 anti-IgM for 4 hours versus Ramos GPF-ZAP-70 
unstimulated (c). The enrichment plot shows GSEA of Ramos GFP-ZAP-70 versus Ramos GFP cells, both 
stimulated with 5 µg/mL F(ab’)2 anti-IgM for 4 hours (d). ES: enrichment score.
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contributing to further dissecting the different elements participating in this pathway is of relevance for the com-
plete understanding of CLL intricate biology.
MicroRNAs have been described to be of relevance for CLL in different facets, nonetheless the first microR-
NAs to be proved to be able to act as tumor suppressors were miR-15a and miR-16-1, which are deleted in around 
50% of cases of CLL26. Also, both overexpression or downregulation of different microRNAs have been related to 
features of aggressive disease, including miR-15527 and miR17-9228 whose expression is regulated by microenvi-
ronmental stimulus, rather than by the presence of genetic alterations. MicroRNA-21 was the second microRNA 
to be directly shown to cause a tumor phenotype in a mouse model, specifically the development of a pre-B 
lymphoproliferative disease, and thus being a genuine oncogene or onco-miR11. Although not being extensively 
studied in CLL, its overexpression has been related to refractoriness to fludarabine15, to a shorter overall survival, 
and to a higher probability of progression16. Also, the cytoprotection offered by IL-4 correlated with miR-21 
fold change in a ex vivo model of CLL29. Herein, we initially described how primary CLL cells with basal high 
Figure 4. Co-culture of primary CLL cells with BMSC, CD40L and CpG ODN induces the expression of miR-
21 and downregulation of the miR-21 targets PTEN, PDCD4 and PIAS3. (a) Primary CLL cells from 40 patients 
were cultured in suspension or in co-culture for 48 hours and miR-21 expression was measured by QRT-PCR. 
(b) Primary CLL cells from 22 patients were cultured in suspension or in co-culture for 48 hours. PTEN, 
PDCD4 and PIAS3 expression was determined by QRT-PCR. (c–d) Relative gene expression comparison 
between matched samples from peripheral blood (PB) and lymph nodes (LN) from 17 treatment-naive CLL 
patients, using public data from Y.Herishanu et al., Blood 201123. mRNA expression level of miR-21 (c) and 
PTEN (d) were analyzed and compared by Wilcoxon matched pairs signed rank test. (e) PBMC from 13 patients 
were pre-treated with 5 µM PCI-32765 for 1 hour and cultured in suspension or in co-culture for 48 hours. 
Expression levels of miR-21 were measured by QRT-PCR. *P < 0.05, **P < 0.01, ***P < 0.0001.
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expression of ZAP-70 also have higher levels of miR-21 expression, which prompted us to further study the 
potential role of ZAP-70 protein in the regulation of the expression of miR-21. However, although the mean 
expression of miR-21 was higher in the group of patients with high expression of ZAP-70, we did not observe a 
significant linear correlation between the percentage ZAP-70-positive CLL cells and the level of miR-21 expres-
sion as assessed by QRT-PCR (data not shown); therefore, even though ZAP-70 is probably directly involved 
in the regulation of the expression of miR-21 in primary CLL cells, it is likely that other proteins and signaling 
pathways are also participating in miR-21 regulation of expression in CLL, precluding the observation of a direct 
positive correlation between miR-21 and ZAP-70 expression in primary CLL cells. ZAP-70 protein has been 
directly involved in previous reports by us and others in the modulation of different proteins implicated in the 
crosstalk of CLL cells with the microenvironment, such as CCR724 and CXCR46. Using a system that we had pre-
viously described24, in which we study the role of ZAP-70 by transfecting mature neoplastic B cells, in this study 
we describe how ZAP-70 participates in the induction of miR-21 transcription by a pathway involving MAPK 
and STAT3 activation.
MicroRNAs can potentially target several different genes, mainly by binding to the 3′UTR region of mRNA 
and controlling mRNA stability and/or translation30; in the particular case of miR-21, the majority of its described 
targets are tumor suppressor genes involved in proliferation, apoptosis or inflammation9,31. For the current study 
we chose to evaluate the three miR-21 target genes, namely PTEN, PDCD4 and PIAS3, defined to be relevant for 
B-cell malignancies. In Ramos expressing ZAP-70 a slight but reproducible downregulation of PTEN, PDCD4 
and PIAS3 at the protein level after BCR activation was detected. In the case of primary CLL cells that were 
co-cultured in conditions mimicking the microenvironment, there was an upregulation of miR-21 expression 
that could be explained in part by the concomitant increase of ZAP-70, while other signals from the microenvi-
ronment are probably involved in the upregulation of miR-21. In this sense, the stimulation of CLL cells with IL-4 
has also been shown to induce upregulation of miR-2129. The co-culture of CLL cells herein described therefore 
induced the upregulation of miR-21 and a subsequent clear downregulation at the mRNA level of PTEN, PDCD4 
and PIAS3, pointing towards the direct downmodulation by miR-21 but not ruling out the possibility of other 
microenvironmental factors involved in the regulation of these tumor suppressors. Remarkably, the increase of 
miR-21 in co-cultured CLL cells did actually correlate with the increase in survival or protection from sponta-
neous apoptosis provided by the microenvironment, again suggesting a clear role for miR-21 and its targets in 
this phenomenon. The upregulation of the BCR pathway that can be induced by ZAP-70 protein is one of the 
differential features observed when comparing paired samples of CLL cells residing in the peripheral blood or 
in the lymph nodes, where the signature of genes related to BCR signaling has been observed to be upregulated. 
Herein, we interrogated the publicly available data on GEP of paired samples from LNs and PB from patients with 
CLL provided by Herishanu and collaborators23 and observed that miR-21 was indeed significantly upregulated 
in LNs according to paired Wilcoxon t-test. The specific analysis of microRNAs differentially expressed between 
LNs and PB in CLL has been recently published by Saleh and collaborators14. They observe that miR-21 is 10 
times higher in CLL compared to normal B cells, and also that the expression is higher in LNs compared to PB, 
although the difference did not reach statistical significance. In order to further relate the increase of miR-21 
that we observed after stimulating primary CLL cells with microenviromental stimuli with BCR signaling we 
inhibited this pathway with the widely used BTK inhibitor ibrutinib, which caused a marked impairment in the 
upregulation of miR-21. In conclusion, we have shown that stimuli from the microenvironment are capable of 
regulating the expression of miR-21 and the tumor suppressor genes (PTEN, PDCD4 and PIAS3) in CLL via a 
Figure 5. Co-culture of primary CLL cells with BMSC, CD40L and CpG ODN increases survival, proliferation 
and miR-21 expression. Survival and miR-21 increase are significantly and positively correlated. PBMC from 
11 patients diagnosed with CLL were maintained in suspension or in co-culture for 48 hours. (a) Linear 
regression analysis of the correlation between fold changes of viability (viability in co-culture versus suspension) 
and fold changes of miR-21 mRNA expression (miR-21 expression in co-culture versus suspension). (b) 
Linear regression analysis of the correlation between fold changes of proliferation (proliferation in co-culture 
versus suspension) and fold changes of miR-21 mRNA expression (miR-21 expression in co-culture versus 
suspension). r2 is the coefficient of determination.
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signaling pathway involving ZAP-70, MAPK and STAT3 transcription factor which correlates with the induction 
of survival by the microenvironment. Although further experiments are warranted in order to fully elucidate 
other factors apart from ZAP-70 involved in the regulation and functional role of miR-21 in CLL, these results 
help to enlighten the biology behind the adverse clinical outcome of patients with CLL having high expression of 
ZAP-70 and enhanced activation of the BCR signaling pathway.
Methods
Primary CLL cells. Peripheral blood mononuclear cells (PBMC) from 77 treatment-naïve patients diagnosed 
with CLL were isolated by Ficoll-Paque Plus (GE Healthcare) density gradient centrifugation and cryopreserved 
in liquid nitrogen until analysis. Patients were selected on the basis of availability of frozen samples for biological 
studies. Written informed consent was obtained from all patients in accordance with the Declaration of Helsinki 
and all experiments were conducted in accordance to such declaration. The study was approved by the clinical 
investigation ethical committee from Vall d’Hebron University Hospital (Barcelona, Spain). ZAP-70 expression 
was determined by flow cytometry: first, the expression of cell surface antigens was detected using the follow-
ing fluorochrome-labeled antibodies: CD19-ECD, CD5-PC5.5 (Beckman Coulter) and CD3-PE-Cy7 (Beckton 
Dickinson) followed by intracellular detection of ZAP-70 using the IntraSure kit (Beckton Dickinson) and pri-
mary antibody anti-ZAP-70-PE (Beckman Coulter). Cases with equal or more than 20% of ZAP-70-positive cells, 
using autologous T cells as an internal control, were considered to be ZAP-70 positive, as previously described4.
For determination of miR-21 expression according to ZAP-70 expression, CD19-positive CLL cells from 33 
cases were purified prior to nucleic acid extraction by positive selection using anti-CD19 magnetic microbeads 
(Miltenyi Biotech). Purity of CD19+ cells greater than 95% was obtained in all samples. For the experiments in 
Figs 4 and 5, additional 44 primary samples from patients with CLL were analyzed. Patient characteristics are 
summarized in Table 1.
Cell lines. Cell lines were cultured in RPMI-1640 medium (Gibco®) supplemented with 10% fetal bovine 
serum (FBS), 50 µg/mL penicillin/streptomycin and 2 mM L-glutamine at 37 °C in a humidified atmosphere 
(5% CO2). Ramos cell line derives from a Burkitt’s lymphoma and it was obtained from American Type Culture 
Collection (ATCC). Ramos cells were stably transfected with a vector encoding for ZAP-70 protein fused with 
Green fluorescent protein (GFP) or GFP only as a control24. Jurkat cells are derived from a T-cell acute lymph-
oblastic leukemia and they were obtained from ATCC. Jurkat cells were stimulated with pervanadate (3 mM 
H2O2/1 mM NaVO4) for 5 minutes at 37 °C, as a positive control for phosphoproteins. Human Bone Marrow 
Stromal Cell (BMSC) cell line UE6E7T-2 was provided by Riken Cell Bank (Ibaraki, Japan) and cultured at 37 °C 
in 5% CO2 atmosphere in Dulbecco’s Modified Eagle Medium (DMEM; Gibco®) supplemented with 2 mM 
L-glutamine, 10% heat-inactivated FBS and 50 µg/mL penicillin/streptomycin.
Co-culture of primary CLL cells. PBMC from patients diagnosed with CLL were co-cultured with BMSC at 
a 100:1 ratio and stimulated with 1 µg/mL CD40L (Peprotech) and 1.5 µg/mL CpG ODN (ODN2006; Invivogen). 
After 48 hours, CLL cells were harvested by gently washing off, leaving the adherent stromal cell layer intact.
Quantitative RT-PCR. Total RNA from cell lines and PBMC from patients was extracted by using TRIzol 
reagent (Invitrogen). For miRNA amplification, RNA was reverse transcribed into single stranded comple-
mentary DNA (cDNA) using ±TaqMan MicroRNA Assays system (Applied Biosystems) and specific primer 
for hsa-miR-21 and RNU6B as control. mRNA was reverse transcribed into cDNA using M-MLV Reverse 
Transcriptase (Invitrogen) according to the manufacturer’s instructions.
Both mRNA and miRNA levels were detected by either TaqMan Assays (PTEN Hs02621230_s1, PDCD4 
Hs00377253_m1, PIAS3 Hs00966035_m1) or TaqMan MicroRNA Assay (hsa-miR-21 000397) (Applied 
Biosystems). RNU6B (001093) and GAPDH (Hs03929097_g1) were used as internal controls for miRNA and 
mRNAs, respectively. Primary miR-21 was amplified with specific primers previously described (see ref.17) and 
quantified using SYBR GreenER qPCR SuperMix. QRT-PCR was performed in an ABI Prism 7900HT Sequence 
Detector System (Applied Biosystems) in triplicates for each cDNA. ABI SDS 2.4 Software (Life Technologies) 
was used to calculate relative expression, using comparative Ct method (ΔΔCt). RNA expression levels are 
defined as arbitrary units (AU) using Ramos cell line as a calibrator.
Immunobloting. BCR was stimulated with 5 µg/mL F(ab)2 anti-IgM (Invitrogen). ERK1/2 and Akt were 
inhibited with PD98059 (Cell Signaling Technology, Inc.) and LY294002 (Sigma-Aldrich), respectively. Protein 
from cell lines was extracted using 20 mM Tris pH 7.4, 1 mM EDTA, 140 mM NaCl, 1% of NP-40 supplemented 
with 2 mM sodium vanadate and protease inhibitor cocktail (Sigma-Aldrich) for 30 minutes at 4 °C. Protein 
concentration was determined using the Bio Rad Protein Assay system (Bio-Rad). Equal amounts of dena-
tured protein were separated by 10% poliacrilamide-SDS gel electrophoresis. The size-separated proteins were 
transferred to Immobilon-phosphate membranes (Millipore). Membranes were blocked with 5% milk/TBS-T 
(Tris-Buffered Saline Tween-20) for 1 hour at room temperature (RT). Membranes were incubated overnight at 
4 °C with primary antibodies against phospho-ZAP-70Tyr319/SykTyr352, phospho-AktSer473, phospho-ERK1/2Thr202/
Tyr204, phospho-STAT3Ser727, Akt, ERK1/2, PTEN and PDCD4 (Cell signalling Technology Inc.), ZAP-70 (clone 
2F3.2; Upstate Biotechnology), PIAS3 (WuXi AppTec.ABGENT) and β-actin (Abcam). Immunodetection was 
done with the corresponding IgG HRP-linked secondary antibodies (Dako North America) for 1 hour at RT. 
Chemiluminescent images were obtained using LAS-4000 equipment (Buckinghamshire).
Cell viability and proliferation. Cell viability was evaluated by surface annexin V-fluorescein isothiocynate 
(FITC) and propidium iodide (PI) double-negative staining assessed by flow cytometry (Bender MedSystems).
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Expression of Ki-67 was used to measure cell proliferation rate by flow cytometry. Surface staining 
of 1 × 106 cells was performed with the following monoclonal antibodies conjugated to a fluorochrome: 
CD19-phycoerythrin (PE) and CD5-allophycocyanine (APC). Intracellular staining was performed using 
FITC-labeled antibody against Ki-67 (Becton Dickinson) after fixation and permeabilization using the BD 
Intrasure kit (Becton Dickinson) following the manufacturer’s instructions. Cells were acquired in a NaviosTM 
cytometer and the results were analyzed using the FCS Express 4 software (De Novo Software).
Statistical analysis. Results are shown as the mean ± standard error of the mean (SEM) of values obtained 
in three or more independent experiments. Statistical analysis between paired samples was performed using 
Student’s paired two-tailed t- test or Wilcoxon matched pairs signed rank test, difference between groups was 
analyzed using the Mann–Whitney U test, and P < 0.05 was considered significant. Gene set enrichment analysis 
(GSEA) was performed using the Gabriely_miR-21_targets gene set from the Molecular Signatures Data Base in 
the GSEA software from the Broad Institute32,33. Linear regression analysis (Spearman’s rank  correlation) was 
used to study the correlation between miR-21 expression and survival or proliferation. Analyses were performed 
using the biostatistics software package SPSS Version 17 (IBM). Results were graphed with GraphPad Prism 
software Version 5.0.
Data Availability. The data that support the findings of this study are available from the corresponding 
author on reasonable request.
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